Introduction

Lung cancer can develop quietly, without causing noticeable symptoms in its early stages. By the time a person starts experiencing a persistent cough, breathlessness or chest discomfort, the disease may have already progressed. This is one of the reasons why lung cancer screening is important for people who have a higher risk of developing the condition.

Lung cancer screening involves checking the lungs for suspicious changes before any symptoms appear. The main screening method used for eligible high-risk individuals is a low-dose computed tomography (LDCT) scan. It uses a lower amount of radiation than a standard chest CT scan and produces detailed images that can help doctors identify small nodules or other abnormalities in the lungs.

Screening does not mean that a person has cancer, nor can it prevent the disease from developing. Its purpose is to identify suspicious findings early so that further investigation can be arranged when necessary. Understanding who may benefit from screening, how the process works and what happens after an abnormal result can help people make informed decisions about their lung health.

Who should consider lung cancer screening?

Lung cancer screening is generally recommended for people who have an increased risk of developing the disease, particularly those with a significant smoking history. Eligibility depends on factors such as age, the number of years a person has smoked, the amount smoked each day and whether they currently smoke or have quit.

People who have worked around certain industrial substances, experienced prolonged exposure to secondhand smoke or have a family history of lung cancer may also have an increased risk. However, these factors do not automatically mean that screening with LDCT is appropriate for everyone.

A doctor can review an individual’s medical and smoking history to determine whether screening is suitable. The benefits and possible risks, including false-positive findings, follow-up procedures and radiation exposure, should be considered before proceeding.

What are the screening methods for lung cancer?

1. Medical History and Risk Assessment

The screening process typically starts off with a discussion about the patient's health and any potential risk factors. The doctor will ask whether the patient currently smokes, whether they have smoked in the past or whether they have regular exposure to tobacco smoke or to certain occupational exposures.

Family history, any previous lung conditions and general health will be looked at. The doctor will decide whether the individual meets the relevant screening criteria and whether they would be likely to benefit from early detection.

This is a crucial point as lung cancer screening is not something that's routinely offered to all adults. It's primarily for those in whom the benefits of screening outweigh the potential risks.

2. Low-Dose Computed Tomography (LDCT) Scan

A low dose CT scan is the main imaging modality used for lung cancer screening in eligible high risk individuals. The scan involves the use of a CT machine to take detailed pictures of the lungs using a low dose of X-rays.

The procedure is generally quick and does not usually require an injection of contrast material. The person lies on a scanning table while images are taken, and the radiologist examines the results for small lung nodules, suspicious masses or other changes that may need attention.

Not every nodule found during screening is cancerous. Some may be related to old infections, inflammation or other non-cancerous conditions. Depending on the size, appearance and characteristics of a finding, the doctor may recommend another CT scan after a specific interval or arrange further investigations.

3. Review of Lung Nodules and Abnormal Findings

One of the important parts of lung cancer screening is determining what an abnormal finding actually means. Small nodules are relatively common, and many do not require an immediate biopsy or other invasive procedure.

The radiologist considers factors such as the nodule’s size, shape, density and appearance. Previous chest scans, when available, can help establish whether a nodule is new, growing or unchanged over time.

Based on these findings, the doctor may recommend routine monitoring, a repeat low-dose CT scan or additional diagnostic tests. A suspicious result should be followed up appropriately, but it should not automatically be interpreted as a confirmed diagnosis of cancer.

4. Follow-Up Imaging

Follow up imaging may be recommended if a screening scan picks up a nodule which needs to be monitored. The timing of the next scan will be determined by the characteristics of the finding and the individual's risk profile.

A stable nodule may only require ongoing monitoring, whereas a nodule that is growing or otherwise more concerning may require further assessment. Scans can be compared over time to look at any changes that may not be evident from a single scan.

It's important to stick to the recommended schedule. Delaying an advised review can make it more difficult to assess a suspicious finding at the right time.

5. Additional Diagnostic Tests When Required

If the screening scan shows an abnormality that raises concern for lung cancer, the doctor may recommend further tests to establish its nature. These investigations are different from screening because their purpose is to evaluate a specific suspected problem.

Depending on the findings, the next steps may include a diagnostic CT scan, PET-CT, bronchoscopy, a needle biopsy or another suitable procedure. A tissue sample may be needed to determine whether cancer is present and, if so, identify its type.

The choice of investigation depends on the location and appearance of the abnormality, the person’s health and the information needed to guide treatment. Not everyone with an abnormal screening result will require a biopsy.

What is the difference between lung cancer screening and diagnosis?

Although screening and diagnosis are closely related, they serve different purposes.

Lung cancer screening is intended for eligible individuals who do not have symptoms, with the aim of finding suspicious changes at an earlier stage. Low-dose CT is the main screening method used for people at increased risk.

Lung cancer diagnosis, on the other hand, involves investigating symptoms or abnormal findings to determine whether cancer is actually present. It may include detailed imaging, bronchoscopy, biopsy, laboratory examination of tissue and other tests.

A screening scan can identify an area of concern, but it cannot always establish the cause. Further testing may be necessary to distinguish lung cancer from benign nodules, infections or other lung conditions.

What happens after an abnormal lung cancer screening result?

An abnormal screening result does not necessarily mean that a person has lung cancer. The next step is to review the scan carefully and determine whether the finding requires monitoring or additional investigation.

The doctor may recommend a repeat scan, a diagnostic CT, PET-CT or a biopsy, depending on the level of concern. If cancer is confirmed, further tests may be required to determine its type and stage before a treatment plan is developed.

Patients should ask their doctor what the scan has shown, when follow-up is required and whether any additional tests are necessary. Keeping previous imaging reports and attending scheduled appointments can also help the medical team make appropriate comparisons.

People who develop symptoms such as coughing up blood, a persistent or worsening cough, unexplained weight loss, chest pain or increasing breathlessness should seek medical evaluation rather than waiting for a routine screening appointment. These symptoms do not always indicate cancer, but they should not be ignored.

Who may not benefit from lung cancer screening?

Screening is not for everyone. A low risk individual may be subjected to unnecessary follow up tests without any real benefit. The same applies to those with symptoms which would point to lung disease in the first place who would require a diagnostic assessment rather than just a screening approach.

The decision also comes down to the individual's general health and whether they would be able and willing to go ahead with treatment should cancer be found. A doctor can help you to work out the potential benefits against the risks (which would include radiation exposure, false positives, anxiety and the potential for finding an abnormality which would never go on to cause any problems at all).

Screening recommendations vary by country and clinical guideline. People should therefore follow advice based on their individual circumstances and locally applicable criteria.

Conclusion

Lung cancer screening offers an opportunity to identify suspicious changes in the lungs before symptoms develop, particularly in people who have a higher risk of the disease. Low-dose CT is the main screening method for eligible individuals, allowing doctors to examine the lungs for nodules or other abnormalities that may require further assessment.

An abnormal result does not confirm cancer, and a normal screening scan cannot guarantee that lung cancer will never develop. Appropriate follow-up, attention to new symptoms and an individual assessment of risk remain important parts of lung health care.

If you have a significant smoking history or other concerns about your risk of lung cancer, consult a qualified doctor to understand whether screening is suitable for you. Early assessment and timely follow-up can help ensure that concerning findings receive appropriate medical attention.

To seek an Expert Consultation for Lung Cancer Screening in Lucknow, India

Call us at +91-9076972161
Email at care@tenderpalm.com

Request a Call Back